Glucose-induced protein kinase C activation regulates vascular permeability factor mRNA expression and peptide production by human vascular smooth muscle cells in vitro

Diabetes

Volumn 46, Issue 9, 1997, Pages 1497-1503

  Williams, Bryan ^a,b   Gallacher, Barbara ^a   Patel, Hashmukh ^a   Orme, Carole ^a  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

^b LEICESTER ROYAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

1 (5 ISOQUINOLINESULFONYL) 2 METHYLPIPERAZINE; CHELERYTHRINE; GLUCOSE; MESSENGER RNA; PROTEIN KINASE C; PROTEIN KINASE C INHIBITOR; VASCULOTROPIN;

ANGIOGENESIS; ARTICLE; BLOOD VESSEL PERMEABILITY; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC ANGIOPATHY; ENZYME ACTIVATION; HUMAN; HUMAN CELL; HYPERGLYCEMIA; MICROVASCULATURE; NEOVASCULARIZATION (PATHOLOGY); PRIORITY JOURNAL; VASCULAR SMOOTH MUSCLE;

EID: 0030863502     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diab.46.9.1497     Document Type: Article

References (42)

1. Jaap AJ, Shore AC, Gartside IB, Gamble J, Tooke JE: Increased microvascular fluid permeability in young insulin dependent diabetic patients. Diabetologia 36:648-652, 1993
2. Jensen T, Feldt-Rasmussen B, Bjerre-Knudson J, Deckert T: Features of endothelial dysfunction in early diabetic nephropathy. Lancet i:461-463, 1989
3. Skrha J, Vackova I, Kvasnicka J, Stibor V, Stolba P, Richter H: Plasma free N-terminal fibronectin 30-kDa domain as a marker of endothelial dysfunction in type I diabetes mellitus. Eur J Clin Invest 20:171-176, 1990
4. Tucker BJ: Early onset of increased transcapillary albumin escape in awake diabetic rats. Diabetes 39:919-923, 1990
5. Leionen H, Mitikainen E, Juntnen J: Permeability and morphology of skeletal muscle capillaries in type I diabetes mellitus. Diabetologia 22:158-162, 1982
6. Dolgov VV, Zaikina OE, Bomdaranko MF, Repin VS: Aortic endotheliurn of Alloxan diabetic rabbits: a quantitative study using scanning electron microscopy. Diabetologia 22:338-343, 1982
7. Diabetes Control and Complications Trial Research Group: The effect of intensive insulin treatment on the development and progression of long-term complications in insulin dependent diabetes mellitus. N Engl J Med 329:977-986, 1993
8. Williams B, Quinn-Baker A, Gallacher B, Lodwick D: Angiotensin II increases vascular permeability factor gene expression by human vascular smooth muscle cells. Hypertension 25:913-917, 1995
9. Aiello LP, Avery R, Arrig P, Keyt BA, Jampel HD, Shah ST, Pasquale IR, Thieme H, Iwamoto MA, Park JE, Nguyen HV, Aeillo LM, Ferrara N, King GL: Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med 331:1480-1487, 1994
10. Ferrara N, Houck K, Jakeman L, Leung DW: Molecular and biological properties of the vascular endothelial growth factor family of proteins. Endocr Rev 13:18-32, 1992
11. Senger DR, Van Der Water L, Brown LF, Nagy JA, Yeo KT, Yeo TK, Berse B, Jackson RW, Dvorak AM, Dvorak HF: Vascular permeability factor in tumor biology. Cancer and Metastasis Rev 12:303-324, 1993
12. Senger DR, Connolly DT, Van Der Water L, Feder J, Dvorak HF: Purification and NH-terminal amino acid sequence of guinea pig tumor-secreted vascular permeability factor. Cancer Res 50:1774-1778, 1990
13. Connolly DT, Heuvelman DM, Nelson R, Olander JV, Eppley BL, Delfino JJ, Seigel NR, Leimgruber RM, Feder J: Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis. J Clin Invest 84:1470-1478, 1989
14. Leung DW, Cachianes G, Kaung WJ, Goeddel WV, Ferrara N: Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 246:1306-1309, 1989
15. Williams B, Quinn-Baker A, Gallacher B: Serum and platelet-derived growth factor-induced vascular permeability factor mRNA expression by human vascular smooth muscle cells in vitro. Clin Sci 88:141-147, 1995
16. Williams B, Gallacher B, Patel H, Orme C: The potential role of vasopressin as a modulator of endothelial function. In. Neurohypophysis: Recent Progress of Vasopressin and Oxytocin Research. Saito T, Kurokawa K, Yoshida S, Eds. New York, Elsevier Sci., 1995, p. 573-582
17. Ferrara N, Winer J, Burton T: Aortic smooth muscle cells express and secrete vascular endothelial growth factor. Growth Factors 5:141-148, 1991
18. Jakeman LB, Winer J, Bennet GL, Altar CA, Ferrara N: Binding sites for vascular endothelial growth factor are localized on endothelial cells in adult rat tissues. J Clin Invest 89:244-253, 1992
19. Terman BI, Carrion ME, Kovacs E, Rasmussen BA, Eddy RL, Shows TB: Identification of a new endothelial cell growth factor receptor tyrosine kinase. Oncogene 6:1677-1683, 1991
20. De Vries C, Escobedo JA, Ueno H, Houck KA, Ferrara N, Williams LT: The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor. Science 255:989-991, 1992
21. Levy AP, Tamargo R, Brem H, Nathans D: An endothelial growth factor from the mouse neuroblastoma cell line NB41. Growth Factors 2:9-19, 1991
22. Berkman RA, Merril MJ, Reinhold WC, Monacci WT, Saxena A, Clark WC, Robertson JT, Ali IU, Oldfield EH: Expression of the vascular permeability factor/vascular endothelial growth factor gene in central nervous system neoplasms. J Clin Invest 91:153-159, 1993
23. Shweiki D, Itin A, Neufeld G, Gitay-Goran H, Keshet E: Patterns of expression of vascular endothelial growth factor (VEGF) and VEGF receptors in mice suggest a role in hormonally regulated angiogenesis. J Clin Invest 91; 2235-2243, 1993
24. Tischer E, Mitchell R, Hartman T, Silva M, Gospodarowicz D: The human gene for vascular endothelial growth factor. J Biol Chem 266:11947-11954, 1991
25. Frank S, Hubner G, Breier G, Longaker MY, Greenhalgh DG, Werner S: Regulation of vascular endothelial growth factor expression in cultured keratinocytes. J Biol Chem 270:12607-12613, 1995
26. Iijima K, Yoshikawa N, Connolly DT, Nakamura H: Human mesangial cells and peripheral blood mononuclear cells produce vascular permeability factor. Kidney Int 44:959-966, 1993
27. Williams B, Schrier RW: Characterization of glucose-induced in situ protein kinase C activity in cultured vascular smooth muscle cells. Diabetes 41:1464-1472, 1992
28. Williams B: Glucose-induced vascular smooth muscle dysfunction: the role of protein kinase C. J Hypertension 13:477-486, 1995
29. Williams B, Tsai P, Schrier RW: Glucose-induced downregulation of angiotensin II and arginine vasopressin receptors in cultured rat aortic vascular smooth muscle cells: role of protein kinase C. J Clin Invest 90:1992-1999, 1992
30. + antiport activity and gene expression in cultured vascular smooth muscle cells: role of protein kinase C. J Clin Invest 93:2623-2631, 1994
31. Xie WQ, Rothblum LI: Rapid, small-scale RNA isolation from tissue culture cells. Biotechniques 11:325-327, 1991
32. Mukhopadhy D, Tsiokas L, Zhou XM, Foster D, Brugge JS, Sukhatme V: Hypoxic induction of human endothelial cell growth factor expression through c-Src activation. Nature 375:577-581, 1995
33. Takagi H, King GL, Robinson GS, Ferrara N, Aiello LP: Adenosine mediates hypoxic induction of vascular endothelial growth factor in retinal microvascular endothelial cells. Inv Ophthal Vis Sci 37:2165-2176, 1996
34. Claffey K, Wilkison WO, Spiegelman BM: Vascular endothelial growth factor regulation by cell differentiation and activated second messenger pathways. J Biol Chem 267:16317-16322, 1992
35. Kunisaki M, Bursell S-E, Umeda F, Nawata H, King GL: Normalization of diacylglycerol-protein kinase C activation by vitamin E in aorta of diabetic rats and cultured rat vascular smooth muscle cells exposed to elevated glucose levels. Diabetes 43:1372-1377, 1994
36. Xia P, Aiello LP, Ishii H, Jiang ZY, Joon Park D, Robinson GS, Takagi H, Newsome WP, Jirousek MR, King GL: Characterization of vascular endothelial growth factor's effect on the activation of protein kinase C, its isoforms and endothelial cell growth. J Clin Invest 98:2018-2026, 1996
37. 2+ and Von Willebrand factor release in human endothelial cells. Am J Pathol 138:213-221, 1991
38. Ross R: The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 362:801-809, 1993
39. Williams B, Schrier RW: Glucose-induced protein kinase C activity regulates arachidonic acid release and eicosanoid production by cultured glomerular mesangial cells. J Clin Invest 92:2889-2896, 1993
40. Simon M, Grone H-J, Johren O, Plate KH, Fuchs E, Risau W: Expression of vascular endothelial growth factor and its receptors in human renal ontogenesis and in adult kidney. Am J Physiol 268:F240-F250, 1995
41. Aiello LP, Pierce EA, Foley ED, Takagi H, Chen H, Riddle L, Ferrara N, King GL, Smith LE: Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins. Proc Natl Acad Sci USA 92:10457-10461, 1995
42. Williamson JR, Chang KC, Stephan CC, Brock TA, Tilton RG: Links between neural and aortic vascular dysfunction by elevated glucose levels and VEGF. Diobetes 45 (Suppl. 2):66A, 1996